We are live on
!
Find out more
AIC
Argus Investors Counsel Portfolio holdings
AUM
$130M
1-Year Est. Return
37.06%
This Fund
S&P 500
This Quarter
Est. Return
-12.67%
1 Year Est. Return
+37.06%
3 Year Est. Return
+123.69%
5 Year Est. Return
+149.89%
10 Year Est. Return
+466.25%
AUM
$192M
AUM Growth
-$40.8M
(-18%)
Cap. Flow
-$8.8M
Cap. Flow
% of AUM
-4.59%
Top 10 Holdings %
Top 10 Hldgs %
22.77%
Holding
69
New
2
Increased
25
Reduced
41
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.46M |
| 2 |
FedEx
FDX
|
+$754K |
| 3 |
Tapestry
TPR
|
+$475K |
| 4 |
SLB Ltd
SLB
|
+$461K |
| 5 |
Arista Networks
ANET
|
+$355K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$1.07M |
| 2 |
Starbucks
SBUX
|
+$831K |
| 3 |
Procter & Gamble
PG
|
+$633K |
| 4 |
Zoetis
ZTS
|
+$502K |
| 5 |
Amgen
AMGN
|
+$492K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.21% |
| 2 | Healthcare | 15.97% |
| 3 | Industrials | 13.6% |
| 4 | Consumer Discretionary | 12.11% |
| 5 | Financials | 12.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Illumina
ILMN
$29B
| $489K | 0.26% |
1,675
+190
| +13% | +$58.9K |
|
52
AbbVie
ABBV
$438B
| $460K | 0.24% |
4,994
+722
| +17% | +$63.5K |
|
|
SCHW
53
Charles Schwab
SCHW
$188B
| $410K | 0.21% |
9,884
+1,383
| +16% | +$62.6K |
|
54
Roper Technologies
ROP
$39.9B
| $408K | 0.21% |
1,532
+200
| +15% | +$56.6K |
|
55
IQVIA
IQV
$39.8B
| $386K | 0.2% |
3,321
+301
| +10% | +$36.5K |
|
56
Honeywell
HON
$77B
| $378K | 0.2% |
3,037
+284
| +10% | +$38.8K |
|
57
Ecolab
ECL
$79.7B
| $367K | 0.19% |
2,490
+318
| +15% | +$48.6K |
|
58
Bio-Techne
TECH
$11.2B
| $347K | 0.18% |
9,604
+1,264
| +15% | +$52.8K |
|
59
Chevron
CVX
$382B
| $338K | 0.18% |
3,109
+387
| +14% | +$44.8K |
|
60
Adobe
ADBE
$109B
| $333K | 0.17% |
1,471
+181
| +14% | +$43.7K |
|
61
Tesla
TSLA
$1.31T
| $330K | 0.17% |
14,865
+1,875
| +14% | +$40.3K |
|
|
62
Arista Networks
ANET
$242B
| $325K | 0.17% |
+24,704
| New | +$355K |
|
63
Travelers Companies
TRV
$78.3B
| $324K | 0.17% |
2,708
+347
| +15% | +$43.4K |
|
|
RTN
64
DELISTED
Raytheon Company
RTN
| $324K | 0.17% |
2,114
+287
| +16% | +$51.4K |
|
65
Meta Platforms (Facebook)
META
$1.52T
| $308K | 0.16% |
2,353
+307
| +15% | +$44.5K |
|
66
Moody's
MCO
$82.8B
| $292K | 0.15% |
2,087
+297
| +17% | +$44.8K |
|
67
Thermo Fisher Scientific
TMO
$222B
| $263K | 0.14% |
+1,176
| New | +$276K |
|
68
Integra LifeSciences
IART
$1.33B
| $243K | 0.13% |
5,386
+839
| +18% | +$46K |
|
69
Bristol-Myers Squibb
BMY
$132B
| – | – |
-5,854
| Closed | -$363K |
|
Similar funds
NCM
CG
EPCA
WM
BM
EPI
OIM
ECP
Argus Investors Counsel's Q4 2018 Portfolio in Review
As of Q4 2018, Argus Investors Counsel held 69 positions worth $192M, down 18% from $232M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Argus Investors Counsel withdrew a net $8.8M in Q4 2018, closing 1 position and reducing 41 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $363K position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Argus Investors Counsel opened a new position in Arista Networks worth $325K.
- Argus Investors Counsel's largest Q4 2018 buy was Arista Networks: 24,704 shares worth $325K.
- Argus Investors Counsel added most to NVIDIA in Q4 2018, an estimated $1.46M increase.
- Argus Investors Counsel's biggest Q4 2018 reduction was IBM, cutting an estimated $1.07M.
- Argus Investors Counsel fully exited Bristol-Myers Squibb in Q4 2018, selling an estimated $363K.
- Argus Investors Counsel's ten largest holdings make up 23% of its $192M portfolio in Q4 2018.
- Argus Investors Counsel opened 2 new positions and closed 1 in Q4 2018.
- Argus Investors Counsel's portfolio value fell 18% quarter-over-quarter to $192M.
Based on Argus Investors Counsel's 13F filing for Q4 2018, filed 6 Feb 2019.